Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

18.8K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
18.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic yield of long-read sequencing for rare diseases: a systematic review.

Frontiers in genetics·2026
Same author

AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical Trial.

JAMA cardiology·2026
Same author

Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource.

Nature·2026
Same author

Detection of differential DNA methylation in date palm (Phoenix dactylifera L.) vitroplants using whole genome bisulfite sequencing analysis.

BMC plant biology·2026
Same author

A large dataset of brain imaging linked to health systems data: curation and access to a whole system national cohort from NHS Scotland.

GigaScience·2026
Same author

Impact of population-specific pharmacogenomic variants on drug dosing in ICU patients.

The pharmacogenomics journal·2026
Same journal

Landscape of copy number variants in Spanish people with dementia.

NPJ genomic medicine·2026
Same journal

Systematic evaluation of long-read and short-read sequencing in neurological disorders diagnosis: a direct comparison study of 310 patients.

NPJ genomic medicine·2026
Same journal

GANomics: bridging legacy and modern transcriptomic platforms for clinical applications.

NPJ genomic medicine·2026
Same journal

BCL2 promoter region mutations are an independent marker of BCL2 level in lymphoid malignancies.

NPJ genomic medicine·2026
Same journal

Dyskeratosis Congenita with Pigmentary Mosaicism and Hematopoietic Trisomy 9 in a Female Associated with a de novo DKC1 Variant and Markedly Skewed X Chromosome Inactivation.

NPJ genomic medicine·2026
Same journal

Two cases of mosaic germline SVA insertions in SMARCB1: implications for rhabdoid tumour predisposition diagnosis.

NPJ genomic medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR (qPCR) Arrays
10:58

Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR (qPCR) Arrays

Published on: December 3, 2010

The QChip1 knowledgebase and microarray for precision medicine in Qatar.

Juan L Rodriguez-Flores1,2, Radja Messai-Badji3, Amal Robay4

  • 1Department of Genetic Medicine, Weill Cornell Medicine, New York, NY, USA.

NPJ Genomic Medicine
|January 20, 2022
PubMed
Summary
This summary is machine-generated.

Researchers developed QChip1, an affordable genotyping microarray, to screen for single-gene disorder (SGD) risk variants in Qatar. The tool identified numerous population-specific variants, highlighting the need for ancestry-tailored genetic screening.

More Related Videos

High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs
07:27

High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs

Published on: August 3, 2011

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Jun 19, 2026

Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR (qPCR) Arrays
10:58

Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR (qPCR) Arrays

Published on: December 3, 2010

High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs
07:27

High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs

Published on: August 3, 2011

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

  • Genetics and Genomics
  • Molecular Biology
  • Population Health

Background:

  • Single-gene disorders (SGDs) share common risk genes across populations, but specific pathogenic variants are often population-private.
  • Qatar, a nation with high consanguinity, requires tailored genetic screening tools for SGDs.
  • Existing genetic screening tools may not adequately capture the unique variant landscape in diverse populations.

Purpose of the Study:

  • To develop and validate QChip1, an inexpensive genotyping microarray for comprehensive screening of SGD risk variants in the Qatari population.
  • To identify population-specific pathogenic variants for SGDs in Qatar.
  • To assess the feasibility of ancestry-specific genetic screening tools.

Main Methods:

  • Genotyping array design incorporating over 10^8 variants from 8445 Qatari individuals.
  • Development of QChip1 with 165,695 probes targeting 83,542 variants across 3438 SGDs.
  • Validation of QChip1 against whole-genome sequencing (WGS) and testing on 2707 Qatari genomes.

Main Results:

  • QChip1 demonstrated high concordance (99.1%) with WGS.
  • Screening identified 32,674 risk variants in 2707 Qatari genomes, averaging 134 pathogenic alleles per individual.
  • The majority (85%) of identified Qatari SGD pathogenic variants were absent in Western populations, and 50% were absent in broader Middle Eastern datasets.

Conclusions:

  • The development of QChip1 proves the feasibility of creating accurate, cost-effective screening tools for SGD risk variants in understudied populations.
  • The study underscores the critical need for ancestry-specific genetic screening tools due to significant population-private variants.
  • QChip1 can facilitate early detection and management of genetic disorders in Qatar and similar populations.